BEYOND HATCH-WAXMAN

被引：0

作者：

Ghosh, Shubha ^{[1
]}

机构：

[1] Univ Wisconsin, Sch Law, Madison, WI 53706 USA

来源：

RUTGERS UNIVERSITY LAW REVIEW | 2015年 / 67卷 / 03期

关键词：

D O I：

暂无

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

页码：779 / 803

页数：25

共 50 条

[41] Overview of the Hatch-Waxman Act and its impact on the drug development process
Mossinghoff, GJ
[J]. FOOD AND DRUG LAW JOURNAL, 1999, 54 (02) : 187 - 194
[42] Hatch-Waxman: Interplay between drug development and lowering pharmaceutical costs
Ahmed, Ali
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[43] Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
Boehm, Garth
Yao, Lixin
Han, Liang
Zheng, Qiang
[J]. ACTA PHARMACEUTICA SINICA B, 2013, 3 (05) : 297 - 311
[44] Rational Antitrust Policy and Reverse Payment Settlements in Hatch-Waxman Patent Litigation
Opderbeck, David W.
[J]. GEORGETOWN LAW JOURNAL, 2010, 98 (05) : 1303 - 1348
[45] DELAYED ACCESS TO GENERIC MEDICINE: A COMMENT ON THE HATCH-WAXMAN ACT AND THE "APPROVAL BOTTLENECK"
Patel, Ankur N.
[J]. FORDHAM LAW REVIEW, 2009, 78 (02) : 1075 - 1115
[46] Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation
Holman, Christopher M.
[J]. BIOTECHNOLOGY LAW REPORT, 2021, 40 (02) : 72 - 94
[47] Patent term extensions for human drugs under the US Hatch-Waxman Act
Boone, Jeffrey S.
[J]. JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2009, 4 (09) : 658 - 664
[48] US Supreme Court could reshape Hatch-Waxman's same labeling requirement
Sullivan, Clark G.
[J]. FUTURE MEDICINAL CHEMISTRY, 2012, 4 (01) : 7 - 8
[49] Patenting drug products: Anticipating Hatch-Waxman issues during the claims drafting process
Mahn, TG
[J]. FOOD AND DRUG LAW JOURNAL, 1999, 54 (02) : 245 - 253
[50] Insurance Coverage and Induced Infringement: A Threat to Hatch-Waxman's Skinny Labeling Pathway?
Lorey, Maya
[J]. UNIVERSITY OF CHICAGO LAW REVIEW, 2023, 90 (05): : 1517 - 1563

← 1 2 3 4 5 →